2.1720
+0.1420
+(7.00%)
At close: January 17 at 5:13:27 PM GMT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
4,995,583.0000
4,995,583.0000
4,438,296.0000
4,137,309.0000
3,772,909.0000
Cost of Revenue
403,297.0000
403,297.0000
351,936.0000
309,313.0000
297,045.0000
Gross Profit
4,592,286.0000
4,592,286.0000
4,086,360.0000
3,827,996.0000
3,475,864.0000
Operating Expense
4,336,644.0000
4,336,644.0000
3,751,893.0000
3,424,714.0000
3,294,980.0000
Operating Income
255,642.0000
255,642.0000
334,467.0000
403,282.0000
180,884.0000
Net Non Operating Interest Income Expense
-292,548.0000
-292,548.0000
-205,851.0000
-201,314.0000
-205,629.0000
Pretax Income
-76,155.0000
-76,155.0000
57,935.0000
133,312.0000
60,057.0000
Tax Provision
-2,568.0000
-2,568.0000
12,162.0000
11,419.0000
17,176.0000
Net Income Common Stockholders
-105,245.0000
-105,245.0000
22,060.0000
91,115.0000
39,402.0000
Diluted NI Available to Com Stockholders
-105,245.0000
-105,245.0000
22,060.0000
91,115.0000
39,402.0000
Basic EPS
-0.62
-0.99
0.13
0.54
0.27
Diluted EPS
-0.62
-0.99
0.08
0.44
0.19
Basic Average Shares
170,587.1900
106,385.0000
168,079.3330
168,837.7830
147,724.6420
Diluted Average Shares
197,059.1920
122,894.0000
193,151.4890
195,931.9390
169,617.0790
Total Operating Income as Reported
163,181.0000
163,181.0000
272,528.0000
341,792.0000
265,904.0000
Total Expenses
4,739,941.0000
4,739,941.0000
4,103,829.0000
3,734,027.0000
3,592,025.0000
Net Income from Continuing & Discontinued Operation
-105,245.0000
-105,245.0000
22,060.0000
91,115.0000
39,402.0000
Normalized Income
-54,514.6576
-54,514.6576
91,586.0581
162,654.2665
56,498.7300
Interest Expense
277,885.0000
277,885.0000
195,900.0000
190,307.0000
194,955.0000
Net Interest Income
-292,548.0000
-292,548.0000
-205,851.0000
-201,314.0000
-205,629.0000
EBIT
201,730.0000
201,730.0000
253,835.0000
323,619.0000
255,012.0000
EBITDA
954,658.0000
954,658.0000
908,717.0000
939,376.0000
811,693.0000
Reconciled Cost of Revenue
403,297.0000
403,297.0000
351,936.0000
309,313.0000
297,045.0000
Reconciled Depreciation
750,308.0000
750,308.0000
617,158.0000
612,719.0000
524,721.0000
Net Income from Continuing Operation Net Minority Interest
-92,440.0000
-92,440.0000
35,741.0000
99,883.0000
39,402.0000
Total Unusual Items Excluding Goodwill
-39,248.0000
-39,248.0000
-70,681.0000
-68,655.0000
-23,945.0000
Total Unusual Items
-39,248.0000
-39,248.0000
-70,681.0000
-68,655.0000
-23,945.0000
Normalized EBITDA
993,906.0000
993,906.0000
979,398.0000
1,008,031.0000
835,638.0000
Tax Rate for Calcs
0.0000
0.0000
0.0002
0.0001
0.0003
Tax Effect of Unusual Items
-1,322.6576
-1,322.6576
-14,835.9419
-5,883.7335
-6,848.2700
12/31/2020 - 12/14/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CHHHF CareRx Corporation
1.4100
-7.84%
TLY.L Totally plc
9.25
0.00%
0NEX.IL Orpea SA
5.73
+6.51%
QC7.SI Q & M Dental Group (Singapore) Limited
0.2750
0.00%
OCA.NZ Oceania Healthcare Limited
0.7700
+2.67%
JNH.V Jack Nathan Medical Corp.
0.0300
0.00%
DCGO DocGo Inc.
4.1700
-2.34%
AGL agilon health, inc.
3.0900
+4.39%